Brooklyn Investment Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$656K Buy
8,190
+1,363
+20% +$112K 0.02% 832
2025
Q4
$593K Sell
6,827
-2,301
-25% -$189K 0.03% 562
2025
Q3
$714K Sell
9,128
-223
-2% -$17.4K 0.1% 209
2025
Q2
$731K Buy
9,351
+6,841
+273% +$510K 0.1% 210
2025
Q1
$182K Sell
2,510
-1,522
-38% -$109K 0.04% 367
2024
Q4
$298K Sell
4,032
-56
-1% -$3.92K 0.09% 189
2024
Q3
$270K Buy
4,088
+112
+3% +$8.14K 0.09% 199
2024
Q2
$375K Hold
3,976
0.16% 138
2024
Q1
$375K Sell
3,976
-118
-3% -$9.91K 0.16% 138
2023
Q4
$312K Buy
+4,094
New +$285K 0.15% 152

Other funds holding EW

Brooklyn Investment Group's EW Position: Q1 2026 in Review

Brooklyn Investment Group increased its Edwards Lifesciences (EW) stake by 20% in Q1 2026, buying an estimated $112K and bringing the position to 8,190 shares worth $656K. The position accounts for 0.02% of the portfolio, ranked #832.

Brooklyn Investment Group first reported a position in EW in Q4 2023 and has held it in 10 quarters since. The position peaked at $731K in Q2 2025. 1,288 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Brooklyn Investment Group held 8,190 shares of Edwards Lifesciences worth $656K as of Q1 2026.
  • Brooklyn Investment Group bought 1,363 Edwards Lifesciences shares in Q1 2026, an estimated $112K.
  • Edwards Lifesciences made up 0.02% of Brooklyn Investment Group's portfolio in Q1 2026, its #832 holding.
  • Brooklyn Investment Group first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 10 quarters since.
  • Brooklyn Investment Group's Edwards Lifesciences position peaked at $731K in Q2 2025.
  • 1,288 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.